These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12387676)

  • 1. Stem cell technologies in regenerative medicine.
    Jain KK
    Expert Opin Biol Ther; 2002 Oct; 2(7):771-3. PubMed ID: 12387676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell treatments for neurodegenerative diseases: challenges from a science, business and healthcare perspective.
    Rosemann A
    Neurodegener Dis Manag; 2015; 5(2):85-7. PubMed ID: 25894869
    [No Abstract]   [Full Text] [Related]  

  • 3. Stem cells Europe 2008.
    Razvi E
    Regen Med; 2009 Jan; 4(1):133-5. PubMed ID: 19105623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cells--SMi's inaugural conference. Drug discovery and therapeutics. 16-17 February 2009, London, UK.
    Kouremenou C
    IDrugs; 2009 Apr; 12(4):211-3. PubMed ID: 19350460
    [No Abstract]   [Full Text] [Related]  

  • 5. Summary of the 12th international symposium on recent advances in stem cell transplantation.
    Ball ED; Ho AD
    Exp Hematol; 2004 Oct; 32(10):881-4. PubMed ID: 15504542
    [No Abstract]   [Full Text] [Related]  

  • 6. Conference scene: Trends in the stem cells marketplace: report from the SSCN Conference 2012.
    Robertson M
    Regen Med; 2012 Jul; 7(4):477-80. PubMed ID: 22817623
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: Current Challenges in Islet Transplantation and Stem Cell Therapies in Diabetes.
    Ramirez-Dominguez M
    Curr Diabetes Rev; 2018; 14(1):2. PubMed ID: 29284395
    [No Abstract]   [Full Text] [Related]  

  • 8. Stem Cells - SMi's second annual conference: achieving success in science and commercialisation.
    Lucifero D
    IDrugs; 2010 Apr; 13(4):232-4. PubMed ID: 20373250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular therapy for childhood neurodegenerative disease. Part II: clinical trial design and implementation.
    Selden NR; Guillaume DJ; Steiner RD; Huhn SL
    Neurosurg Focus; 2008; 24(3-4):E23. PubMed ID: 18341400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dental stem cells: myth or hope in neuroregenerative medicine?].
    Dimassi S; Relaño-Ginés A; Hirtz C; Lehmann S; Deville de Périère D
    Ann Biol Clin (Paris); 2020 Dec; 78(6):593-603. PubMed ID: 33361014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cells and pancreatic differentiation in vitro.
    Blyszczuk P; Wobus AM
    J Biotechnol; 2004 Sep; 113(1-3):3-13. PubMed ID: 15380643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cells--a hard sell to investors.
    Giebel LB
    Nat Biotechnol; 2005 Jul; 23(7):798-800. PubMed ID: 16003359
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential use of stem cells in neuroreplacement therapies for neurodegenerative diseases.
    Sugaya K
    Int Rev Cytol; 2003; 228():1-30. PubMed ID: 14667041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell therapy: opportunities and challenges.
    England S
    Curr Opin Investig Drugs; 2004 Jul; 5(7):704-5. PubMed ID: 15298064
    [No Abstract]   [Full Text] [Related]  

  • 15. [The perspectives of hepatic failure treatment by stem cells].
    Dolgikh MS
    Biomed Khim; 2008; 54(4):376-91. PubMed ID: 18988455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2010 World Stem Cell Summit--part 1. October 4-6, 2010, Detroit, MI, USA.
    Vertès A
    IDrugs; 2010 Dec; 13(12):819-21. PubMed ID: 21154132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cells as a resource for regenerative neurology.
    Connick P; Patani R; Chandran S
    Pract Neurol; 2011 Feb; 11(1):29-36. PubMed ID: 21239652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The function of stem cells and their future roles in healthcare.
    Cedar SH
    Br J Nurs; 2006 Jan 26-Feb 8; 15(2):104-7. PubMed ID: 16493287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in stem cells technologies and their commercialization potential.
    Kamarul T
    Expert Rev Clin Pharmacol; 2013 Jul; 6(4):363-5. PubMed ID: 23927663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailoring human embryonic stem cells for neurodegenerative disease therapy.
    Sonntag KC; Sanchez-Pernaute R
    Curr Opin Investig Drugs; 2006 Jul; 7(7):614-8. PubMed ID: 16869113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.